Page last updated: 2024-08-23

pravastatin and Angiitis

pravastatin has been researched along with Angiitis in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (66.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
David, S; Fliser, D; Haller, H; Kielstein, JT; Kümpers, P; Lukasz, A	1
Brookes, ZL; Brown, NJ; Hellewell, PG; McGown, CC; Reilly, CS	1
Atar, I; Aydınalp, A; Bozbaş, H; Konaş, D; Korkmaz, ME; Mermer, S; Müderrisoğlu, H; Ozin, B; Yıldırır, A	1
Buchholz, K; Fliser, D; Haller, H	1
Apperson-Hansen, C; Churchill, T; Crowe, T; Lin, S; Loyd, A; Magyar, WA; Nicholls, SJ; Nissen, SE; Schoenhagen, P; Sipahi, I; Tuzcu, EM; Wang, C; Wolski, K	1
Egashira, K; Inoue, S; Kataoka, C; Kitamoto, S; Koyanagi, M; Ni, W; Takeshita, A	1

Trials

4 trial(s) available for pravastatin and Angiitis

Article	Year
Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin. Journal of hypertension, 2009, Volume: 27, Issue:8 Topics: Adult; Aged; Angiopoietin-2; Angiotensin II Type 1 Receptor Blockers; Atherosclerosis; C-Reactive Protein; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Male; Middle Aged; Pravastatin; Prospective Studies; Tetrazoles; Vasculitis	2009
Pravastatin therapy fails to suppress post-PCI inflammatory response measured by serum neopterin and CRP levels. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2011, Volume: 11, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Angina, Stable; Angioplasty, Balloon, Coronary; C-Reactive Protein; Dose-Response Relationship, Drug; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Neopterin; Pravastatin; Premedication; Stents; Vasculitis	2011
Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation, 2004, Aug-31, Volume: 110, Issue:9 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Arteriosclerosis; Biomarkers; C-Reactive Protein; Chemokine CCL2; Cholesterol; Comorbidity; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Intercellular Adhesion Molecule-1; Interleukin-6; Lipids; Male; Middle Aged; Olmesartan Medoxomil; Pravastatin; Prospective Studies; Receptor, Angiotensin, Type 1; Tetrazoles; Treatment Outcome; Tumor Necrosis Factor-alpha; Vasculitis	2004
Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. Circulation, 2006, Jun-20, Volume: 113, Issue:24 Topics: Adaptation, Physiological; Adult; Aged; Atorvastatin; C-Reactive Protein; Cardiac Catheterization; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Female; Follow-Up Studies; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Models, Cardiovascular; Pravastatin; Prospective Studies; Pyrroles; Risk Factors; Single-Blind Method; Triglycerides; Ultrasonography, Interventional; Vasculitis	2006

Other Studies

2 other study(ies) available for pravastatin and Angiitis

Article	Year
Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III. British journal of anaesthesia, 2010, Volume: 104, Issue:2 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Capillary Permeability; Cell Adhesion; Drug Evaluation, Preclinical; Endothelium, Vascular; Endotoxemia; Leukocytes; Lipopolysaccharides; Male; Microcirculation; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Wistar; Vasculitis	2010
Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions. Hypertension research : official journal of the Japanese Society of Hypertension, 2000, Volume: 23, Issue:4 Topics: Animals; Anticholesteremic Agents; Blood Pressure; Chemokine CCL2; Cholesterol; Coronary Vessels; Gene Expression; Male; Nitric Oxide; Pravastatin; Rats; Rats, Inbred WKY; RNA, Messenger; Systole; Time Factors; Vasculitis	2000

Article

Year

Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III.

British journal of anaesthesia, 2010, Volume: 104, Issue:2

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Pressure; Capillary Permeability; Cell Adhesion; Drug Evaluation, Preclinical; Endothelium, Vascular; Endotoxemia; Leukocytes; Lipopolysaccharides; Male; Microcirculation; Nitric Oxide Synthase Type III; Pravastatin; Rats; Rats, Wistar; Vasculitis

2010

Pravastatin attenuates cardiovascular inflammatory and proliferative changes in a rat model of chronic inhibition of nitric oxide synthesis by its cholesterol-lowering independent actions.

Hypertension research : official journal of the Japanese Society of Hypertension, 2000, Volume: 23, Issue:4

Topics: Animals; Anticholesteremic Agents; Blood Pressure; Chemokine CCL2; Cholesterol; Coronary Vessels; Gene Expression; Male; Nitric Oxide; Pravastatin; Rats; Rats, Inbred WKY; RNA, Messenger; Systole; Time Factors; Vasculitis

2000